Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q1 EPS of $0.12, $0.36 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $55.13 million versus the consensus estimate of $30.84 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.